Phase I/II study of gemcitabine and nab-paclitaxel with radiation therapy in patients with pancreatic cancer.
Not Applicable
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000017751
- Lead Sponsor
- Department of Surgery, Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1)bowel movement control is difficult, because of watery diarrhea and chronic diarrhea. (2)Interstitial pneumonia or pulmonary fibrosis diagnosed by chest X-ray and with symptom (3)Pleural effusion or ascitic fluid accumulates (4)with clinically important infection (5)has active carcinoma except carcinoma in situ (6)with gastrointestinal active ulcer (7)sever complication(heart failure, renal failure,liver failure,intestinal paralysis,uncontrollable diabetes etc) (8)severe mental disorder (9)severe drug allergy (10)pregnant women or during the nursing, women who like be pregnant and willing to get pregnant (11)doctors decision not to be registered to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method